Ignite Creation Date:
2025-12-24 @ 3:37 PM
Ignite Modification Date:
2026-01-03 @ 10:38 PM
Study NCT ID:
NCT04779892
Status:
COMPLETED
Last Update Posted:
2021-10-11
First Post:
2021-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety
Sponsor:
Taizhou Mabtech Pharmaceutical Co.,Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CMAB008HV-I
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None